1. Home
  2. NLSP vs KRKR Comparison

NLSP vs KRKR Comparison

Compare NLSP & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • KRKR
  • Stock Information
  • Founded
  • NLSP 2015
  • KRKR 2010
  • Country
  • NLSP Switzerland
  • KRKR China
  • Employees
  • NLSP N/A
  • KRKR N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • KRKR Business Services
  • Sector
  • NLSP Health Care
  • KRKR Consumer Discretionary
  • Exchange
  • NLSP Nasdaq
  • KRKR Nasdaq
  • Market Cap
  • NLSP 6.2M
  • KRKR 6.6M
  • IPO Year
  • NLSP 2021
  • KRKR 2019
  • Fundamental
  • Price
  • NLSP $1.81
  • KRKR $3.64
  • Analyst Decision
  • NLSP
  • KRKR
  • Analyst Count
  • NLSP 0
  • KRKR 0
  • Target Price
  • NLSP N/A
  • KRKR N/A
  • AVG Volume (30 Days)
  • NLSP 2.2M
  • KRKR 19.8K
  • Earning Date
  • NLSP 10-18-2024
  • KRKR 09-03-2024
  • Dividend Yield
  • NLSP N/A
  • KRKR N/A
  • EPS Growth
  • NLSP N/A
  • KRKR N/A
  • EPS
  • NLSP N/A
  • KRKR N/A
  • Revenue
  • NLSP N/A
  • KRKR $41,654,350.00
  • Revenue This Year
  • NLSP N/A
  • KRKR $45.99
  • Revenue Next Year
  • NLSP N/A
  • KRKR $31.46
  • P/E Ratio
  • NLSP N/A
  • KRKR N/A
  • Revenue Growth
  • NLSP N/A
  • KRKR N/A
  • 52 Week Low
  • NLSP $1.73
  • KRKR $2.76
  • 52 Week High
  • NLSP $20.80
  • KRKR $12.20
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 40.38
  • KRKR 51.29
  • Support Level
  • NLSP $1.87
  • KRKR $3.21
  • Resistance Level
  • NLSP $2.08
  • KRKR $3.60
  • Average True Range (ATR)
  • NLSP 0.20
  • KRKR 0.21
  • MACD
  • NLSP 0.01
  • KRKR 0.04
  • Stochastic Oscillator
  • NLSP 2.33
  • KRKR 66.86

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About KRKR 36Kr Holdings Inc.

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.

Share on Social Networks: